Clinical Trial Search

Primary: Change in Mental Health-related Quality of Life From Baseline to 24 Weeks — 8.87; 8.39 units on a scale — p=0.002

Primary: Change in Average Daily Alcohol Consumption — -3.4; -3.0 alcoholic drinks per day

Primary: Number of Participants Reporting Solicited Injection-Site and Solicited Systemic Reactions Following Vaccination With the 2013-2014 Formulation of Fluzone® Quadrivalent…

Primary: Change in Serum Catecholamines — 87; 106 mcg/ml — p=0.940

Primary: Change From Baseline in Disease Activity 28 (DAS28) Score — -3.9 score on a scale

Primary: Change in Intraocular Pressure During Nitrous Oxide Sedation — 1.05 mmHg (difference in IOP) — p=>0.05

Primary: Serum Markers of Skeletal Turnover (Serum CTX) — 0.9887; 0.5445 ng/mL

Primary: Use of the IUD for Contraception at Six Months — 49; 51 participants — p=0.24

Primary: Percentage of Participants With Improvement of Greater Than or Equal to [≥]5 Milliliters Per Minute Per 1.73 Square Meters (mL/Min/m^2) in Calculated Glomerular…

Primary: Percentage of Participants Achieving a Psoriasis Area and Severity Index 75 (PASI 75) Response at Week 24 — 82.0 percentage of participants

Primary: Change From Baseline in Digit Span Test Total Score at Week 12 — 11.7; 13.7; 1; 0.5 Scores on a scale — p=0.0387

Primary: Pain Rating Index — -3.7 units on a scale

Primary: Pain Scores (NRS) at 3-weeks — 6; 3 units on a scale — p=0.279

Primary: Conversion From Atrial Fibrillation to Sinus Rhythm — 8; 5 participants

Primary: Change From Baseline in Hemoglobin A1C (HbA1C) at Week 30 — -1.5; -0.7 Percent of total hemoglobin — p=<0.001